Synergy acquires Bristol-Myers' shingles product

Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) acquired FV-100 from Bristol-Myers Squibb Co. (NYSE:BMY) on Thursday, six months after the pharma gained the shingles product through its $2.5 billion takeov...